Ibuprofen API Market: Analyzing the Growing Demand for Pain Relief Medicines in the Ibuprofen API Industry

The Ibuprofen API Market Outlook

The growth of the Ibuprofen API Market is attributed to the growing prevalence of chronic diseases such as arthritis and osteoarthritis, expansion of the pharmaceutical industry in developing countries, and the increasing demand for nonsteroidal anti-inflammatory drugs (NSAIDs) for pain management.

Moreover, the increasing demand for Ibuprofen API in the manufacturing of various drugs such as analgesics, anti-inflammatory drugs, and anti-rheumatics, is expected to have a positive impact on the market growth. Additionally, the rising demand for over-the-counter (OTC) drugs for pain relief is also expected to contribute to the market growth.

Download PDF Sample here: https://growthmarketreports.com/request-sample/4701

Market Trends

The Ibuprofen API market has witnessed significant trends that are expected to shape the future of the market. One of the significant trends is the increasing adoption of Ibuprofen API in the manufacturing of generic drugs. The pharmaceutical industry is focusing on the production of generic drugs due to their cost-effectiveness and easy accessibility.

Another significant trend is the increasing demand for Ibuprofen API for the treatment of pediatric patients suffering from arthritis and other inflammatory diseases. As per the studies, Ibuprofen API is safe and effective for the treatment of pediatric patients, and hence, the demand for the API is expected to increase in the near future.

Furthermore, the rising demand for Ibuprofen API in the manufacturing of sports medicines is also expected to fuel the market growth. The use of Ibuprofen API in sports medicine is gaining popularity among athletes and sports enthusiasts due to its pain-relieving properties.

Enquiry Before Buying: https://growthmarketreports.com/enquiry-before-buying/4701

Growth Factors

The global Ibuprofen API market is expected to grow significantly during the forecast period due to several growth factors. One of the significant growth factors is the increasing prevalence of chronic diseases such as arthritis and osteoarthritis. According to the World Health Organization (WHO), around 10% to 15% of the adult population worldwide suffers from arthritis, and this number is expected to increase in the near future.

Moreover, the expansion of the pharmaceutical industry, particularly in developing countries such as India, China, and Brazil, is expected to drive the market growth. The increasing demand for OTC drugs for pain relief is also expected to contribute to the market growth.

Another growth factor is the increasing number of surgical procedures being performed worldwide. According to the statistics by the Organization for Economic Cooperation and Development (OECD), the number of surgical procedures performed globally has increased from 234 million in 2000 to 313 million in 2017. This increasing number of surgical procedures is expected to increase the demand for NSAIDs, including Ibuprofen API.

Major Players

The global Ibuprofen API market is highly competitive with the presence of several major players. Some of the prominent players operating in the market include BASF SE, Xinhua Pharmaceutical Co., Ltd, IOLCP, Granules India, Shire (Acquired by Takeda Pharmaceutical), Hisun Pharma, Anguo Qiancheng Pharmaceutical Co., LGM Pharma., Hangzhou Hetd Industry Co., Ltd, and Zhejiang Hongyuan Pharmaceutical Co., Ltd.

These players are adopting various strategies such as mergers & acquisitions, collaborations, and partnerships to strengthen their market position. For instance, in June 2020, BASF SE announced the completion of its acquisition of the Solvay polyamide business. This acquisition is expected to strengthen BASF SE’s position as a leading supplier of engineering plastics. Similarly, in September 2019, Shire, a subsidiary of Takeda Pharmaceutical, announced the acquisition of Prevalynx LLC. This acquisition is expected to strengthen Shire’s position in the development of innovative treatments for gastrointestinal diseases.

Get Full Access to this Report: https://growthmarketreports.com/checkout/4701

Conclusion

The global Ibuprofen API market is expected to witness significant growth during the forecast period. The growing prevalence of chronic diseases, the expansion of the pharmaceutical industry, and the increasing demand for NSAIDs are the major factors contributing to the market growth. However, the market is highly competitive, with the presence of several major players. These players are adopting various strategies to strengthen their market position. Therefore, it is essential for companies to adopt innovative strategies and technologies to stay competitive in the market.”